Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 14

1.

N-acetylcysteine prevents loss of dopaminergic neurons in the EAAC1-/- mouse.

Berman AE, Chan WY, Brennan AM, Reyes RC, Adler BL, Suh SW, Kauppinen TM, Edling Y, Swanson RA.

Ann Neurol. 2011 Mar;69(3):509-20. doi: 10.1002/ana.22162. Epub 2010 Nov 23.

2.

Glial reactions in Parkinson's disease.

McGeer PL, McGeer EG.

Mov Disord. 2008 Mar 15;23(4):474-83. Review.

PMID:
18044695
3.

Age and Parkinson's disease-related neuronal death in the substantia nigra pars compacta.

Eriksen N, Stark AK, Pakkenberg B.

J Neural Transm Suppl. 2009;(73):203-13. Review.

PMID:
20411779
4.

Inflammation as a causative factor in the aetiology of Parkinson's disease.

Whitton PS.

Br J Pharmacol. 2007 Apr;150(8):963-76. Epub 2007 Mar 5. Review.

5.

Glutathione metabolism and Parkinson's disease.

Smeyne M, Smeyne RJ.

Free Radic Biol Med. 2013 Sep;62:13-25. doi: 10.1016/j.freeradbiomed.2013.05.001. Epub 2013 May 8. Review.

6.

Inflammation and infection in Parkinson's disease.

Arai H, Furuya T, Mizuno Y, Mochizuki H.

Histol Histopathol. 2006 Jun;21(6):673-8. doi: 10.14670/HH-21.673. Review.

PMID:
16528677
7.

Ferroptosis and cell death mechanisms in Parkinson's disease.

Guiney SJ, Adlard PA, Bush AI, Finkelstein DI, Ayton S.

Neurochem Int. 2017 Mar;104:34-48. doi: 10.1016/j.neuint.2017.01.004. Epub 2017 Jan 9. Review.

PMID:
28082232
8.

Chronic microglial activation and progressive dopaminergic neurotoxicity.

Block ML, Hong JS.

Biochem Soc Trans. 2007 Nov;35(Pt 5):1127-32. Review.

PMID:
17956294
9.

Oxidative and nitrative protein modifications in Parkinson's disease.

Danielson SR, Andersen JK.

Free Radic Biol Med. 2008 May 15;44(10):1787-94. doi: 10.1016/j.freeradbiomed.2008.03.005. Epub 2008 Mar 18. Review.

10.

Thiol-redox signaling, dopaminergic cell death, and Parkinson's disease.

Garcia-Garcia A, Zavala-Flores L, Rodriguez-Rocha H, Franco R.

Antioxid Redox Signal. 2012 Dec 15;17(12):1764-84. doi: 10.1089/ars.2011.4501. Epub 2012 May 3. Review.

11.

Protein stability and aggregation in Parkinson's disease.

Robinson PA.

Biochem J. 2008 Jul 1;413(1):1-13. doi: 10.1042/BJ20080295. Review.

PMID:
18537793
12.

Regulation of myocyte enhancer factor-2 transcription factors by neurotoxins.

She H, Mao Z.

Neurotoxicology. 2011 Oct;32(5):563-6. doi: 10.1016/j.neuro.2011.05.019. Epub 2011 Jun 29. Review.

13.

Anti-Oxidants in Parkinson's Disease Therapy: A Critical Point of View.

Filograna R, Beltramini M, Bubacco L, Bisaglia M.

Curr Neuropharmacol. 2016;14(3):260-71. Review.

14.

Calcium and Parkinson's disease.

Surmeier DJ, Schumacker PT, Guzman JD, Ilijic E, Yang B, Zampese E.

Biochem Biophys Res Commun. 2017 Feb 19;483(4):1013-1019. doi: 10.1016/j.bbrc.2016.08.168. Epub 2016 Aug 30. Review.

PMID:
27590583

Supplemental Content

Support Center